The effects of proton pump inhibition on patient‐reported severity of dyspepsia when receiving dual anti‐platelet therapy with clopidogrel and low‐dose aspirin: analysis from the Clopidogrel and the Optimization of Gastrointestinal Events Trial

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|42|3|365-374

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.42, Iss.3, 2015-08, pp. : 365-374

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Using prophylactic proton pump inhibitor

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 3, 2015-03 ,pp. : 478-484

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gastrointestinal Adverse Events after Dual Antiplatelet Therapy: Clopidogrel Is Safer than Ticagrelor, but Prasugrel Data Are Lacking or Inconclusive

By  

Cardiology, Vol. 126, Iss. 1, 2013-07 ,pp. : 35-40

Karger

Access to resources Recommend Favorite

Triple versus Dual Antiplatelet Therapy in Acute Coronary Syndromes: Adding Cilostazol to Aspirin and Clopidogrel?

By  

Cardiology, Vol. 126, Iss. 4, 2013-10 ,pp. : 233-243

Karger

Access to resources Recommend Favorite

Combination Antiplatelet Therapy with Aspirin and Clopidogrel: The Role of Antecedent and Concomitant Doses of Aspirin

By  

Cardiology, Vol. 107, Iss. 4, 2007-01 ,pp. : 307-312

Karger

Access to resources Recommend Favorite

High-dose fibrinogen concentrate for haemostatic therapy of a major trauma patient with recent clopidogrel and aspirin intake

By Schöchl Herbert   Posch Alexander   Hanke Alexander   Voelckel Wolfgang   Solomon Cristina  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 70, Iss. 6, 2010-10 ,pp. : 453-457

Informa Healthcare

Access to resources Recommend Favorite